Q&A: Science Has Been “Resilient” During Pandemic, Survey Finds

Responses collected from around 25,000 academics reveal that 20 percent couldn’t do their work at all in the spring, but most had found ways to keep their research going.

Written byCatherine Offord
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

ABOVE: © ISTOCK.COM,
YORKFOTO

Scientists, like everyone else, have had to adapt creatively to the pandemic this year—whether by making labs out of their laundry rooms or quickly pivoting their research to SARS-CoV-2 and the disease it causes. In late October, journal publisher Frontiers reported results from a survey that asked those researchers how the pandemic has affected their lives. Based on data collected in May and June from 25,307 participants worldwide, the findings offer insight into scientists’ working conditions in the time of COVID-19, their attitudes to how scientific findings should be shared, and their biggest concerns for the future.

The Scientist spoke to Frontiers’s marketing and communications director Chantelle Rijs, who led the study along with executive editor Frederick Fenter, to learn more about the survey and its findings.

Chantelle Rijs: We are all very passionate about science and we are very passionate about the role that science plays ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies